Table 1 |
||||||
|
Medication prescriptions among Medicaid enrollees with incident SLE, 2000 to 2004 according to county-level SESa |
||||||
|
Corticosteroids |
Hydroxychloroquine |
Immunosuppressantsb |
||||
|
|
||||||
|
OR |
95% CI |
OR |
95% CI |
OR |
95% CI |
|
|
|
||||||
|
Increasing county-level SES |
0.94 |
0.89-0.99 |
1.04 |
0.99-1.09 |
1.12 |
1.05-1.20 |
|
|
||||||
|
aMultivariable logistic regression models adjusted for number of Medicaid-enrolled months, age at first SLE claim, race/ethnicity, sex, geographic region, Health Professional Shortage Area, and state-level number of rheumatologists. bImmunosuppressants include: azathioprine, mycophenolate mofetil, cyclophosphamide (oral and intravenous), cyclosporine or tacrolimus |
||||||
|
Feldman et al. Arthritis Research & Therapy 2012 14(Suppl 3):A7 doi:10.1186/ar3941 |
||||||